1. Impressive results for Parkinsons Patients - NAC trialed at Thomas Jefferson Univ
    pamela dixon pamela dixon United States says:
    August 5, 2016 at 11:46 AM

    Couple of questions:
    1) Was this a Phase I or Phase II study?  Who funded it and why?

    2) Can you help us understand the significance of the results  "improvements of 4-9 percent in dopamine transporter binding" and "improvements in their UPDRS score of about 13 percent."  What does this mean?  Where there some improvements that were specifically noteworthy, i.e., tremor?

    3) Why isn't this study getting more attention?  If it can enable dopamine neurons to recover some function would that not be amazing?

    Reply
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback